These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15750833)

  • 21. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
    Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
    Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and therapeutic efficacy of a dual-component genetic cancer vaccine cotargeting carcinoembryonic antigen and HER2/neu in preclinical models.
    Aurisicchio L; Peruzzi D; Koo G; Wei WZ; La Monica N; Ciliberto G
    Hum Gene Ther; 2014 Feb; 25(2):121-31. PubMed ID: 24195644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection.
    Böcher WO; Dekel B; Schwerin W; Geissler M; Hoffmann S; Rohwer A; Arditti F; Cooper A; Bernhard H; Berrebi A; Rose-John S; Shaul Y; Galle PR; Löhr HF; Reisner Y
    Eur J Immunol; 2001 Jul; 31(7):2071-9. PubMed ID: 11449360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen design enhances the immunogenicity of Semliki Forest virus-based therapeutic human papillomavirus vaccines.
    Ip PP; Boerma A; Walczak M; Oosterhuis K; Haanen JB; Schumacher TN; Nijman HW; Daemen T
    Gene Ther; 2015 Jul; 22(7):560-7. PubMed ID: 25756550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
    Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
    Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Individual analysis of mice vaccinated against a weakly immunogenic self tumor-specific antigen reveals a correlation between CD8 T cell response and antitumor efficacy.
    Rosato A; Zoso A; Milan G; Macino B; Dalla Santa S; Tosello V; Di Carlo E; Musiani P; Whalen RG; Zanovello P
    J Immunol; 2003 Nov; 171(10):5172-9. PubMed ID: 14607917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critical components of a DNA fusion vaccine able to induce protective cytotoxic T cells against a single epitope of a tumor antigen.
    Rice J; Buchan S; Stevenson FK
    J Immunol; 2002 Oct; 169(7):3908-13. PubMed ID: 12244189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasmid DNA vaccines against cancer: cytotoxic T-lymphocyte induction against tumor antigens.
    Pavlenko M; Leder C; Pisa P
    Expert Rev Vaccines; 2005 Jun; 4(3):315-27. PubMed ID: 16026247
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.
    Ye J; Chen GS; Song HP; Li ZS; Huang YY; Qu P; Sun YJ; Zhang XM; Sui YF
    Cancer Immunol Immunother; 2004 Sep; 53(9):825-34. PubMed ID: 15127237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S; Lee JB; Lee GK; Chang J
    Prostate; 2009 Jun; 69(9):938-48. PubMed ID: 19267351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity.
    Wang L; Rollins L; Gu Q; Chen SY; Huang XF
    Vaccine; 2009 Dec; 28(2):561-70. PubMed ID: 19835823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of Semliki Forest virus based self-amplifying RNA expressing Indian HIV-1C genes in mice.
    Ajbani SP; Velhal SM; Kadam RB; Patel VV; Bandivdekar AH
    Int J Biol Macromol; 2015 Nov; 81():794-802. PubMed ID: 26361864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhancement of tumor-specific immune response with plasmid DNA replicon vectors.
    Leitner WW; Ying H; Driver DA; Dubensky TW; Restifo NP
    Cancer Res; 2000 Jan; 60(1):51-5. PubMed ID: 10646851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.
    Karanikas V; Lurquin C; Colau D; van Baren N; De Smet C; Lethé B; Connerotte T; Corbière V; Demoitié MA; Liénard D; Dréno B; Velu T; Boon T; Coulie PG
    J Immunol; 2003 Nov; 171(9):4898-904. PubMed ID: 14568971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.
    Colmenero P; Chen M; Castaños-Velez E; Liljeström P; Jondal M
    Int J Cancer; 2002 Apr; 98(4):554-60. PubMed ID: 11920615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
    Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
    Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
    Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
    Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A suicidal DNA vaccine expressing the fusion protein of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in mice.
    Wang Y; Yue X; Jin H; Liu G; Pan L; Wang G; Guo H; Li G; Li Y
    J Virol Methods; 2015 Dec; 225():35-40. PubMed ID: 26343487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Designer Cross-reactive DNA Immunotherapeutic Vaccine that Targets Multiple MAGE-A Family Members Simultaneously for Cancer Therapy.
    Duperret EK; Liu S; Paik M; Trautz A; Stoltz R; Liu X; Ze K; Perales-Puchalt A; Reed C; Yan J; Xu X; Weiner DB
    Clin Cancer Res; 2018 Dec; 24(23):6015-6027. PubMed ID: 30262507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine.
    Okamoto T; Kaneda Y; Yuzuki D; Huang SK; Chi DD; Hoon DS
    Gene Ther; 1997 Sep; 4(9):969-76. PubMed ID: 9349434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.